{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:32:35Z","timestamp":1764732755974,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cancergen.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T18:07:29Z","timestamp":1535479649000},"page":"28-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases"],"prefix":"10.1016","volume":"228-229","author":[{"given":"Francesca","family":"Magnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-6525","authenticated-orcid":false,"given":"Lisa","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-9717","authenticated-orcid":false,"given":"Ilaria","family":"Proserpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-2966","authenticated-orcid":false,"given":"Leonardo","family":"Campiotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Tibiletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.cancergen.2018.08.001_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdw175","article-title":"Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Vitolo","year":"2016","journal-title":"Ann Oncol"},{"year":"2017","series-title":"WHO Classification of Tumours od Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.cancergen.2018.08.001_bib0002"},{"issue":"1","key":"10.1016\/j.cancergen.2018.08.001_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","volume":"124","author":"M\u00f8ller","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cancergen.2018.08.001_bib0005","first-page":"10","article-title":"Primary extranodal B-cell lymphoma: current concepts and treatment strategies","volume":"4","author":"Vannata","year":"2015","journal-title":"Chin Clin Oncol"},{"issue":"8","key":"10.1016\/j.cancergen.2018.08.001_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part I: gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.cancergen.2018.08.001_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1369\/0022155411417309","article-title":"Genotypic and phenotypic differences between nodal and extranodal diffuse large B-cell lymphomas","volume":"59","author":"Al-Humood","year":"2011","journal-title":"J Histochem Cytochem"},{"issue":"12","key":"10.1016\/j.cancergen.2018.08.001_bib0008","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","article-title":"Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin","volume":"23","author":"Lopez-Guillermo","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cancergen.2018.08.001_bib0009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database","volume":"89","author":"Castillo","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2018.08.001_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcmd.2015.12.004","article-title":"Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites","volume":"57","author":"Wang","year":"2016","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"10.1016\/j.cancergen.2018.08.001_bib0011","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3109\/10428194.2013.834055","article-title":"Gene translocations in testicular lymphomas","volume":"55","author":"Bernasconi","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergen.2018.08.001_bib0012","first-page":"1","article-title":"Primary testicular diffuse large B-cell lymphoma: morphological and immunophenotypical study with characterization of the T-cell component of the tumor microenvironment","volume":"17","author":"Magnoli","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.cancergen.2018.08.001_bib0013","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/10428190802087447","article-title":"Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: a single centre experience","volume":"49","author":"Uccella","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.cancergen.2018.08.001_bib0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cancergencyto.2004.03.005","article-title":"Specificity of interphase fluorescent in situ hybridization for detection of chromosome aberrations in tumor pathology","volume":"155","author":"Tibiletti","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"10.1016\/j.cancergen.2018.08.001_bib0016","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.humpath.2008.06.032","article-title":"BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome","volume":"40","author":"Tibiletti","year":"2009","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.cancergen.2018.08.001_bib0017","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V78.10.2680.2680","article-title":"Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma","volume":"78","author":"Raghoebier","year":"1991","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cancergen.2018.08.001_bib0018","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cancergen.2018.08.001_bib0019","first-page":"453","article-title":"Extranodal non-Hodgkin's lymphomas - a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas","volume":"9","author":"Lal","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5045\/kjh.2011.46.2.103","article-title":"Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma","volume":"46","author":"Jang","year":"2011","journal-title":"Korean J Hematol"},{"issue":"5","key":"10.1016\/j.cancergen.2018.08.001_bib0021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clml.2011.05.037","article-title":"Biological characterization of nodal versus extranodal presentation of diffuse large B-cell lymphoma using immunohistochemistry","volume":"11","author":"Kim","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.cancergen.2018.08.001_bib0022","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdg004","article-title":"Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry","volume":"14","author":"Krol","year":"2003","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.cancergen.2018.08.001_bib0023","first-page":"697","article-title":"Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different","volume":"51","author":"Connor","year":"2007","journal-title":"An Immunohistochem Clin Stud Histopathol"},{"issue":"9","key":"10.1016\/j.cancergen.2018.08.001_bib0024","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/10428190802238552","article-title":"Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas","volume":"49","author":"Mitchell","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.cancergen.2018.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.3800691","article-title":"Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases","volume":"19","author":"Al-Abbadi","year":"2006","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2399","article-title":"Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways","volume":"216","author":"Booman","year":"2008","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.cancergen.2018.08.001_bib0027","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.prp.2010.04.005","article-title":"Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype","volume":"206","author":"Li","year":"2010","journal-title":"Pathol Res Pract"},{"issue":"12","key":"10.1016\/j.cancergen.2018.08.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114398","article-title":"MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system","volume":"9","author":"Gill","year":"2014","journal-title":"Plos One"},{"issue":"12","key":"10.1016\/j.cancergen.2018.08.001_bib0029","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/annonc\/mds150","article-title":"Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study","volume":"23","author":"de Leval","year":"2012","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.cancergen.2018.08.001_bib0030","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","article-title":"Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas","volume":"16","author":"Sarkozy","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.10333","article-title":"Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma","volume":"73","author":"Sohn","year":"2003","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.cancergen.2018.08.001_bib0032","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2014.1.90","article-title":"Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC","volume":"2014","author":"Swerdlow","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"12","key":"10.1016\/j.cancergen.2018.08.001_bib0033","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"Quesada","year":"2017","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.cancergen.2018.08.001_bib0034","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell Lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.cancergen.2018.08.001_bib0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnen\/61.10.926","article-title":"Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system","volume":"61","author":"Montesinos-Rongen","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"10.1016\/j.cancergen.2018.08.001_bib0036","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.jnen.0000229988.48042.ae","article-title":"Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination","volume":"65","author":"Schwindt","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.cancergen.2018.08.001_bib0037","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5507\/bp.2012.085","article-title":"Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL)","volume":"157","author":"Nedomova","year":"2013","journal-title":"Biomed Pap Med Fac Univ Palacky Olomuc Czech Repub"},{"issue":"2","key":"10.1016\/j.cancergen.2018.08.001_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"issue":"22","key":"10.1016\/j.cancergen.2018.08.001_bib0039","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cancergen.2018.08.001_bib0040","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.leukres.2014.04.009","article-title":"Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma","volume":"38","author":"Olszewski","year":"2014","journal-title":"Leuk Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218300929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:25Z","timestamp":1761896605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218300929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"alternative-id":["S2210776218300929"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.08.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}